Join
Live feed
·
INSIDERFilingvia Quantisnow
Summit Therapeutics Inc. logo

SEC Form 4: Dhingra Ankur bought $36,554 worth of shares (37,685 units at $0.97), increasing direct ownership by 49% to 39,527 units (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.
SMMT· Summit Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SMMT (Summit Therapeutics Inc.) and more on Quantisnow.